Correlation Between Viridian Therapeutics and Concurrent Technologies
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Concurrent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Concurrent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Concurrent Technologies Plc, you can compare the effects of market volatilities on Viridian Therapeutics and Concurrent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Concurrent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Concurrent Technologies.
Diversification Opportunities for Viridian Therapeutics and Concurrent Technologies
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Concurrent is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Concurrent Technologies Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Concurrent Technologies and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Concurrent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Concurrent Technologies has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Concurrent Technologies go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Concurrent Technologies
Assuming the 90 days trading horizon Viridian Therapeutics is expected to generate 10.46 times less return on investment than Concurrent Technologies. In addition to that, Viridian Therapeutics is 1.35 times more volatile than Concurrent Technologies Plc. It trades about 0.03 of its total potential returns per unit of risk. Concurrent Technologies Plc is currently generating about 0.46 per unit of volatility. If you would invest 13,750 in Concurrent Technologies Plc on November 3, 2024 and sell it today you would earn a total of 4,550 from holding Concurrent Technologies Plc or generate 33.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Concurrent Technologies Plc
Performance |
| Timeline |
| Viridian Therapeutics |
| Concurrent Technologies |
Viridian Therapeutics and Concurrent Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Concurrent Technologies
The main advantage of trading using opposite Viridian Therapeutics and Concurrent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Concurrent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concurrent Technologies will offset losses from the drop in Concurrent Technologies' long position.| Viridian Therapeutics vs. Zoom Video Communications | Viridian Therapeutics vs. Gamma Communications PLC | Viridian Therapeutics vs. MTI Wireless Edge | Viridian Therapeutics vs. Bloomsbury Publishing Plc |
| Concurrent Technologies vs. Samsung Electronics Co | Concurrent Technologies vs. Samsung Electronics Co | Concurrent Technologies vs. Toyota Motor Corp | Concurrent Technologies vs. Reliance Industries Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |